Recurrent Breast Cancer Active Not Recruiting Phase 1 Trials for Vorinostat (DB02546)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01084057Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast CancerTreatment